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The academic year 2011/2012 is now four 
months old, and we are off to a splendid 
start! We (a) have welcomed several new 
faculty members and a bolus of categorical 
interns (see below), (b) had a leadership 
transition at our Methodist Hospital, (c) are 
in growth mode at Methodist with initiatives 
in General Surgery, Vascular Surgery, 
Wound Care and Surgical Oncology (see 
the cover story), and (d) with the leadership 
of Dr. Nicholas Cavarocchi have seen 
remarkable growth in our adult ECMO 
program with outstanding clinical results 
and several research projects brought to 
fruition. Exciting times again this year  
at Jefferson!
I want to take this opportunity to also praise 
the Jefferson Foundation and particularly 
Lara Goldstein who returned from her recent 
maternity leave at full throttle. As Director of 
Development for the Department of Surgery, 
Lara has been instrumental in the tripling 
of philanthropic support to the Department 
between 2006 and 2011. She has partnered 
well with our researchers to assist with 
grant submissions and with our clinicians 
in building relationships with our grateful 
patients. Lara’s efforts have also culminated 
in a recent estate gift to the Department 
(see Those Who Give) directed towards the 
support of our surgical fellowships. It is 
important that we all redouble our efforts 
to bring support to the Department, as we 
grow our volumes and our footprint in the 
Delaware Valley. 
Addendum: 
Just prior to going to press, we learned of 
the passing of our esteemed colleague, Dr. 
John H. Moore, Jr., on September 26, 2011. 
John was a committed Jeffersonian who 
touched the lives of thousands of patients, 
residents, students and staff. He was also 
a sage advisor. A fund, “The John H. Moore 
Jr., MD, Surgical Residency Fund” has been 
initiated in his honor.
The Jefferson Surgical Cardiac Care Unit 
(SCCU), reorganized in July 2010, delivers 
the best survival rates in Pennsylvania for 
patients plagued by serious lung and/or 
heart dysfunction. Nicholas Cavarocchi, 
MD, FACS, FCCP, the SCCU Director 
and Associate Professor of Surgery, 
leads a highly trained team that uses 
extracorporeal membrane oxygenation (an 
ECMO machine) to provide respiratory 
and cardiac support to patients whose 
lungs and/or hearts cannot function 
on their own. Because of the excellent 
outcomes – 70 to 80 percent survival 
rates for patients with life-threatening 
situations, up from a previous zero-based 
survival rate – Dr. Cavarocchi believes the 
Jefferson SCCU model will ultimately be 
adopted by all hospitals.
“Our SCCU model brings together the 
ECMO technology and a team of cardiac 
physicians, nurses and mid-level providers 
all trained in complex critical care,” Dr. 
Cavarocchi says. “We have implemented 
standardized management of patient care 
using established protocols built with 
evidence-based medicine.” Jefferson’s 
SCCU is currently the only service in the 
nation led by cardiothoracic surgeons, 
rather than anesthesiologists or other 
medical doctors. The team physicians, who 
are all board-certified in thoracic surgery, 
also include Harrison Pitcher, MD, Hitoshi 
Hirose, MD, PhD, FACS, and Michel 
Haddad, MD. The rest of the team is 
comprised of physicians assistants Angela 
Kelley, PA, Tamara Boucher, PA and Sarah 
Langan, PA-C, and nurse practitioner 
Megan McCullough, CRNP.
Surgeon-led ECMO Treatment 
Improves Survival Rates in 
Surgical Cardiac Care Unit
Four board-certified thoracic surgeons, Drs. Cavarocchi, Haddad, Pitcher and Hirose,  
staff the Surgical Cardiac Care Unit at Jefferson – the only service in the nation led by 
cardiothoracic surgeons.
Overview Clinical Integration
We have welcomed an amazing new group 
of categorical interns, selected from over 
one thousand applicants to our program. 
These doctors, who recently matched with 
Jefferson Medical College (JMC), started on 
June 20, 2011. Just a few months into their 
Jefferson surgical residency, we have all 
noticed their dedication to patient care, their 
energy and their excitement in joining the 
Jefferson community. 
Meet Our Surgical Interns
Please welcome (from left to right):
Christine Feldmeier, MD, JMC
James Crawford, MD, New York University
Kate Holoyda, MD, University of Wisconsin
Vishen Sooppan, MD, SUNY Upstate - Syracuse
Caitlyn Johnson, MD, JMC
Jonathan Sarik, MD, JMC
Based on the principles of a machine 
that was invented in the 1950s and first 
used successfully in humans at Jefferson 
Hospital by John Gibbon, Jr., MD, 
ECMO takes a patient’s blood, gives it 
oxygen, warms it and returns it to the 
patient. Today’s ECMO machine, with 
its innovative circuitry, newer membrane 
oxygenator and centrifugal pump is a 
completely different machine but the 
concept is the same. Complemented 
by the SCCU team’s comprehensive 
approach, ECMO treatment helps avoid 
serious complications such as bleeding 
and hemolysis (the breakdown of red 
blood cells) and allows the heart and/or 
lungs to recover. At Jefferson, patients are 
placed on ECMO earlier than usual, ideally 
before the patient has organ failure. This 
improves their chances of either being 
successfully weaned from ECMO or having 
surgery with fewer complications, and that 
reduces costs for both the hospital and  
the patient. 
The SCCU currently treats about 30 
patients annually but that number is 
expected to increase by 50% this year with 
referrals from within and out-of-state. 
“Our team has been trained to deliver 
a level of complex critical care that is 
sophisticated and consistent,” notes Dr. 
Cavarocchi, “Our patients are benefiting 
and our colleagues are noticing.”
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